1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| IWP-2 | IWP-2 | 686770-61-6 |
| Emodin | 大黄素 | 518-82-1 |
| ICG-001 | ICG-001 | 780757-88-2 |
| Prinaberel | 普林贝瑞 | 524684-52-4 |
| XAV-939 | 3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮 | 284028-89-3 |
| Chroman 1 | (3S)-N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-3,4-二氢-6-甲氧基-2H-1-苯并吡喃-3-甲酰胺 | 1273579-40-0 |
| HhAntag | N-[4-氯-3-[5-(二甲基氨基)-1H-苯并咪唑-2-基]苯基]-3,5-二甲氧基苯甲酰胺 | 496794-70-8 |
| ML-7 hydrochloride | 1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐 | 110448-33-4 |
| GSK269962A | N-[3-[[2-(4-氨基呋咱-3-基)-1-乙基-1H-咪唑并[4,5-C]吡啶-6-基]氧]苯基]-4-[[2-(4-吗啉基)乙基]氧]苯甲酰胺 | 850664-21-0 |
| Wnt-C59 | PORCN酶活性和WNT抑制剂(WNT-C59) | 1243243-89-1 |
| Ripasudil | (2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物 | 887375-67-9 |
| SAR407899 hydrochloride | 6-(哌啶-4-氧基)异喹啉-1(2H)-酮盐酸盐 | 923262-96-8 |
| SAR407899 | SAR407899 | 923359-38-0 |
| LH846 | LH-846 | 639052-78-1 |
| H-1152 dihydrochloride | 871543-07-6 | 871543-07-6 |
| Glasdegib | 格拉斯吉布 | 1095173-27-5 |
| Sonidegib diphosphate | SONIDEGIB PHOSPHATE | 1218778-77-8 |
| Sonidegib | 索尼吉布 | 956697-53-3 |
| Saridegib | IPI-926 | 1037210-93-7 |
| iCRT 14 | ICRT-14 | 677331-12-3 |
| Verosudil | VEROSUDIL | 1414854-42-4 |
| LGK974 | 2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺 | 1243244-14-5 |
| RU-SKI 43 hydrochloride | RU-SKI 43 HCL;HHAT INHIBITOR | 1782573-67-4 |
| LEQ506 | 1204975-42-7 | 1204975-42-7 |
| ETC-159 | 1,2,3,6-四氢-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-哒嗪基)-7H-嘌呤-7-乙酰胺 | 1638250-96-0 |
| JW74 | JW74;JW 74 | 863405-60-1 |
| BML-284 | WNT AGONIST 1 (CID11210285 盐酸盐) | 853220-52-7 |
| Silmitasertib sodium salt | 1309357-15-0 | 1309357-15-0 |
| Pyrvinium pamoate | 扑蛲灵 | 3546-41-6 |
| Pamidronic acid | 帕米膦酸 | 40391-99-9 |
| Nefopam D3 | NefopaM-d3 Hydrochloride | 1346747-15-6 |
| Oxymatrine | 氧化苦参碱 | 16837-52-8 |
| Wogonin | 汉黄芩素 | 632-85-9 |
| Halofuginone | 常山酮 | 55837-20-2 |
| Halofuginone hydrobromide | 氢溴酸卤夫酮 | 64924-67-0 |
| L-Quebrachitol | (-)-白雀木醇 | 642-38-6 |
| N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide | (9Z,12Z,15Z)-N-[(3-甲氧基苯基)甲基]-9,12,15-十八碳三烯酰胺 | 883715-23-9 |
| Super-TDU | Super-TDU | 1599441-71-0 |
| YAP-TEAD-IN-1 TFA | YAP-TEAD-IN-1 TFA | 1659305-79-9 |
| ROCK-IN-1 | 934387-35-6 | 934387-35-6 |
| Calcipotriol monohydrate | CALCIPOTRIOL MONOHYDRATE | 147657-22-5 |
| Alfacalcidol | 阿法骨化醇 | 41294-56-8 |
| CB1151 | CB1151 | 182369-28-4 |
| ZK159222 | ZK 159222 | 156965-15-0 |
| TEI-9647 | (5S)-5-[(2R)-2-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]propyl]-3-methylideneoxolan-2-one | 173388-20-0 |
| ZK168281 | FUDAEUIGIJZUAY-UMIRZPQISA-N | 186371-96-0 |
| 1alpha-Hydroxy VD4 | 1ALPHA-羟基维生素 D4 | 143032-85-3 |
| Impurity B of Calcitriol | 表骨化三醇 | 66791-71-7 |
| Impurity C of Calcitriol | PRE-骨化三醇PTAD加合物 | 86307-44-0 |
| Impurity C of Alfacalcidol | 阿法骨化醇杂质 C | 82266-85-1 |
| Calcifediol-D6 | 骨化二醇-D6 | 78782-98-6 |
| Calcitetrol | 1ALPHA,24,25-三羟基生素 D3 | 72203-93-1 |
| 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 | 25 - 羟基维生素D33,3' - 氨基丙基醚 | 163018-26-6 |
| MC 1046 | MC 1046 | 126860-83-1 |
| Impurity F of Calcipotriol | 1,3-二-O-(叔-丁基二甲基硅烷基)卡泊三醇 | 112875-61-3 |
| (24S)-MC 976 | (1ALPHA,3BETA,5Z,7E,24S)-24-环丙基-9,10-开环胆甾-5,7,10(19)-三烯-1,3,24-三醇 | 112849-14-6 |
| 25-Hydroxy VD2-D6 | 25-羟基维生素 D2-D6 | 1262843-46-8 |
| VD3-D6 | 维生素 D3-D6 | 118584-54-6 |
| Alfacalcidol-D6 | 阿尔法骨化醇-D6 | 1641940-94-4 |
| (24S)-24,25-Dihydroxyvitamin D3 | 24S,25-二羟基维他命 D3 | 55700-58-8 |
| TBCA | Casein Kinase II Inhibitor III | 934358-00-6 |
| WAY-262611 | MAY-262611 | 1123231-07-1 |
| Casein Kinase II Inhibitor IV | 863598-09-8 | 863598-09-8 |
| YAP/TAZ inhibitor-1 | 2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime | 2093565-23-0 |
| Porcn-IN-1 | Porcupine-IN-1 | 2036044-77-4 |
| NRX-252262 | 化合物NRX-252262 | 2438637-61-5 |
| DK419 | DK419 | 2102672-22-8 |
| CUR61414 | CUR 61414 | 334998-36-6 |
| FzM1.8 | Fzd4 agonist FzM1.8) | 2204290-85-5 |
| ALLO-2 | ALLO-2 (Smo inhibitor ALLO-2) | 1357350-60-7 |
| MRT00033659 | MRT00033659 | 1401731-54-1 |
| ROCK inhibitor-2 | ROCK inhibitor-2 | 1127308-52-4 |
| SSTC3 | SSTC3 | 1242422-09-8 |
| MSAB | MSAB | 173436-66-3 |
| Dynarrestin | Dynarrestin | 2222768-84-3 |
| IWR-1 | IWR-1 | 1127442-82-3 |
| Glabrescione B | GLABRESCIONE B | 65893-94-9 |
| Ciliobrevin D | Cilliobrevin D | 1370554-01-0 |
| Cardiogenol C hydrochloride | 2-[[2-[(4-甲氧基苯基)氨基]-4-嘧啶基]氨基]乙醇盐酸盐 | 1049741-55-0 |
| BDP5290 | BDP5290 | 1817698-21-7 |
| TED-347 | 化合物TED-347 | 2378626-29-8 |
| HSD1590 | HSD1590 | 2379279-96-4 |
| LX7101 | LX7101 | 1192189-69-7 |
| CCT251545 | CCT251545 | 1661839-45-7 |
| I3MT-3 | 4(3H)-Pyrimidinone, 6-methyl-2-[[2-(1-naphthalenyl)-2-oxoethyl]thio]- | 459420-09-8 |
| SAG | SAG | 912545-86-9 |
| SAG hydrochloride | 2095432-58-7 | 2095432-58-7 |
| NCC007 | NCC007游离态 | 2342583-66-6 |
| IWP-4 | CS-2394 | 686772-17-8 |
| (E)-SIS3 | SIS3 | 521984-48-5 |
| Taladegib | 4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 | 1258861-20-9 |
| GANT 58 | 4,44乔,4乔(2,3,4,5-Thiophentetrayl)tetrakis-pyridine | 64048-12-0 |
| SR-3677 | N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-2,3-二氢-1,4-苯并二恶烷-2-甲酰胺 | 1072959-67-1 |
| JK184 | N-(4-乙氧基苯基)-4-(2-甲基咪唑并[1,2-A]吡啶-3-基)噻唑-2-胺 | 315703-52-7 |
| PF-5274857 | PF-5274857 | 1373615-35-0 |
| Wnt pathway activator 1 | 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenylbutane-1,4-dione | 1360540-81-3 |
| FIDAS-5 | FIDAS-5 | 1391934-98-7 |
| β-catenin-IN-2 | β-catenin-IN-2 | 1458664-10-2 |
| BMS-833923 | BMS-833923 | 1059734-66-5 |
| Hydroxyfasudil | 羟基法舒地尔 | 105628-72-6 |
联系方式
